Systemic lupus erythematosus and malignancies risk

Journal of Cancer Research and Clinical Oncology

Volumn 142, Issue 1, 2016, Pages 253-262

  Mao, Song ^a   Shen, Hua ^b   Zhang, Jianhua ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Malignancy; Meta analysis; Systemic lupus erythematosus

Indexed keywords

ADULT; AMERICAN; ANUS CANCER; ARTICLE; ASIAN; CANCER RISK; COLON CANCER; DISEASE DURATION; ESOPHAGUS CANCER; EUROPEAN; FEMALE; FOLLOW UP; GALLBLADDER CANCER; HEAD AND NECK CANCER; HUMAN; INCIDENCE; INVESTIGATIVE PROCEDURES; KIDNEY CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM CANCER; RETROSPECTIVE STUDY; RISK ASSESSMENT; STUDY DESIGN; SYSTEMIC LUPUS ERYTHEMATOSUS; THYROID CANCER; UTERINE CERVIX CANCER; VAGINA CANCER; VULVA CANCER; AGE; CHINA; COMPLICATION; FACTUAL DATABASE; META ANALYSIS (TOPIC); NEOPLASMS; PROGNOSIS; RISK FACTOR;

AGE FACTORS; CHINA; DATABASES, FACTUAL; FEMALE; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; META-ANALYSIS AS TOPIC; NEOPLASMS; PROGNOSIS; RISK FACTORS;

EID: 84953637202     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-015-2032-0     Document Type: Article

References (50)

1. Abu-Shakra M, Gladman DD, Urowitz MB (1996) Malignancy in systemic lupus erythematosus. Arthritis Rheum 39:1050–1054
2. Antonelli A, Mosca M, Fallahi P, Neri R, Ferrari SM, D’Ascanio A, Ghiri E, Carli L, Miccoli P, Bombardieri S (2010) Thyroid cancer in systemic lupus erythematosus: a case–control study. J Clin Endocrinol Metab 95:314–318
3. Appenzeller S, Pallone AT, Natalin RA, Costallat LT (2009) Prevalence of thyroid dysfunction in systemic lupus erythematosus. J Clin Rheumatol 15:117–119
4. Artinian V, Kvale PA (2004) Cancer and interstitial lung disease. Curr Opin Pulm Med 10:425–434
5. Azevedo PC, Murphy G, Isenberg DA (2014) Pathology of systemic lupus erythematosus: the challenges ahead. Methods Mol Biol 1134:1–16
6. Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Urowitz M, Gladman D, Fortin P, Gordon C, Barr S, Edworthy S, Bae SC, Petri M, Sibley J, Isenberg D, Rahman A, Steinsson K, Aranow C, Dooley MA, Alarcon GS, Hanly J, Sturfelt G, Nived O, Pope J, Ensworth S, Rajan R, El-Gabalawy H, McCarthy T, St Pierre Y, Clarke A, Ramsey-Goldman R (2005) Race/ethnicity and cancer occurrence in systemic lupus erythematosus. Arthritis Rheum 53:781–784
7. Bernatsky S, Ramsey-Goldman R, Foulkes WD, Gordon C, Clarke AE (2011) Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis. Br J Cancer 104:1478–1481
8. Bernatsky S, Ramsey-Goldman R, Labrecque J, Joseph L, Boivin JF, Petri M, Zoma A, Manzi S, Urowitz MB, Gladman D, Fortin PR, Ginzler E, Yelin E, Bae SC, Wallace DJ, Edworthy S, Jacobsen S, Gordon C, Dooley MA, Peschken CA, Hanly JG, Alarcón GS, Nived O, Ruiz-Irastorza G, Isenberg D, Rahman A, Witte T, Aranow C, Kamen DL, Steinsson K, Askanase A, Barr S, Criswell LA, Sturfelt G, Patel NM, Senécal JL, Zummer M, Pope JE, Ensworth S, El-Gabalawy H, McCarthy T, Dreyer L, Sibley J, St Pierre Y, Clarke AE (2013) Cancer risk in systemic lupus: an updated international multi-centre cohort study. J Autoimmun 42:130–135
9. Björnådal L, Löfström B, Yin L, Lundberg IE, Ekbom A (2002) Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol 31:66–71
10. Burns KA, Korach KS (2012) Estrogen receptors and human disease: an update. Arch Toxicol 86:1491–1504
11. Carson SD, Johnson DR (1990) Consecutive enzyme cascades: complement activation at the cell surface triggers increased tissue factor activity. Blood 76:361–367
12. Cervera R, Doria A, Amoura Z, Khamashta M, Schneider M, Guillemin F, Maurel F, Garofano A, Roset M, Perna A, Murray M, Schmitt C, Boucot I (2014) Patterns of systemic lupus erythematosus expression in Europe. Autoimmun Rev S1568–9972(14):00009–00013
13. Chang SL, Hsu HT, Weng SF, Lin YS (2013) Impact of head and neck malignancies on risk factors and survival in systemic lupus erythematosus. Acta Otolaryngol 133:1088–1095
14. Chen YJ, Chang YT, Wang CB, Wu CY (2010) Malignancy in systemic lupus erythematosus: a nationwide cohort study in Taiwan. Am J Med 123:1150.e1–1150.e6
15. Cibere J, Sibley J, Haga M (2001) Systemic lupus erythematosus and the risk of malignancy. Lupus 10:394–400
16. Dey D, Kenu E, Isenberg DA (2013) Cancer complicating systemic lupus erythematosus—a dichotomy emerging from a nested case–control study. Lupus 22:919–927
17. Ekblom-Kullberg S, Kautiainen H, Alha P, Helve T, Leirisalo-Repo M, Julkunen H (2009) Reproductive health in women with systemic lupus erythematosus compared to population controls. Scand J Rheumatol 38:375–380
18. Feng X, Wu H, Grossman JM, Hanvivadhanakul P, FitzGerald JD, Park GS, Dong X, Chen W, Kim MH, Weng HH, Furst DE, Gorn A, McMahon M, Taylor M, Brahn E, Hahn BH, Tsao BP (2006) Association of increased interferon-inducible gene expression with disease activity and lupus nephritis inpatients with systemic lupus erythematosus. Arthritis Rheum 54:2951–2962
19. Gayed M, Bernatsky S, Ramsey-Goldman R, Clarke A, Gordon C (2009) Lupus and cancer. Lupus 18:479–485
20. Ghaussy NO, Sibbitt W Jr, Bankhurst AD, Qualls CR (2003) Cigarette smoking and disease activity in systemic lupus erythematosus. J Rheumatol 30:1215–1221
21. Golder V, Connelly K, Staples M, Morand E, Hoi A (2013) Association of Asian ethnicity with disease activity in SLE: an observational study from the Monash Lupus clinic. Lupus 22:1425–1430
22. Hemminki K, Liu X, Ji J, Sundquist J, Sundquist K (2012) Effect of autoimmune diseases on risk and survival in histology-specific lung cancer. Eur Respir J 40:1489–1495
23. Hidalgo-Conde A, de Haro Liger M, Abarca-Costalago M, Álvarez Pérez M, Valdivielso –Felices P, González-Santos P, Fernández-Nebro A (2013) Incidence of cancer in a cohort of Spanish patients with systemic lupus erythematosus. Reumatol Clin 9:359–364
24. Itzkowitz SH, Yio X (2004) Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 287:G7–G17
25. Kang KY, Kim HO, Yoon HS, Lee J, Lee WC, Ko HJ, Ju JH, Cho CS, Kim HY, Park SH (2010) Incidence of cancer among female patients with systemic lupus erythematosus in Korea. Clin Rheumatol 29:381–388
26. Kasama Y, Mizukami T, Kusunoki H, Peveling-Oberhag J, Nishito Y, Ozawa M, Kohara M, Mizuochi T, Tsukiyama-Kohara K (2014) B-cell-intrinsic hepatitis C virus expression leads to B-cell-lymphomagenesis and induction of NF-κB signalling. PLoS ONE 9:e91373
27. Khalesi M, Whiteman DC, Tran B, Kimlin MG, Olsen CM, Neale RE (2013) A meta-analysis of pigmentary characteristics, sun sensitivity, freckling and melanocytic nevi and risk of basal cell carcinoma of the skin. Cancer Epidemiol 37:534–543
28. Kim MN, Kim BK, Han KH (2013) Hepatocellular carcinoma in patients with chronic hepatitis C virus infection in the Asia–Pacific region. J Gastroenterol 48:681–688
29. Kiss Emese, Kovacs Laszlo, Szodoray Peter (2010) Malignancies in systemic lupus erythematosus. Autoimmun Rev 9:195–199
30. Liang JA, Sun LM, Yeh JJ, Lin WY, Chang SN, Sung HC, Kao CH (2012) Malignancies associated with systemic lupus erythematosus in Taiwan: a nationwide population-based cohort study. Rheumatol Int 32:773–778
31. Lim SS, Bayakly AR, Helmick CG, Gordon C, Easley KA, Drenkard C (2014) The incidence and prevalence of systemic lupus erythematosus, 2002–2004: the georgia lupus registry. Arthritis Rheumatol 66:357–368
32. Lin YC, Yen JH, Chang SJ, Lin YC (2012) The age-risk relationship of haematologic malignancies in female patients with systemic lupus erythematosus: a nationwide retrospective cohort study. Lupus 21:1250–1256
33. Matera L, Mori M, Geuna M, Buttiglieri S, Palestro G (2000) Prolactin in autoimmunity and antitumor defence. J Neuroimmunol 109:47–55
34. Mellemkjaer L, Andersen V, Linet MS, Gridley G, Hoover R, Olsen JH (1997) Non-Hodgkin’s lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum 40:761–768
35. Moss KE, Ioannou Y, Sultan SM, Haq I, Isenberg DA (2002) Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis 61:409–413
36. Ni J, Qiu LJ, Hu LF, Cen H, Zhang M, Wen PF, Wang XS, Pan HF, Ye DQ (2014) Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis. Lupus 23:284–292
37. Parikh-Patel A, White RH, Allen M, Cress R (2008) Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California. Cancer Causes Control 19:887–894
38. Pettersson T, Pukkala E, Teppo L, Friman C (1992) Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis 51:437–439
39. Ramos-Casals M, Muñoz S, Medina F, Jara LJ, Rosas J, Calvo-Alen J, Brito-Zerón P, Forns X, Sánchez-Tapias JM (2009) HISPAMEC Study Group. Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry). J Rheumatol 36:1442–1448
40. Ruffatti A, Aversa S, Del Ross T, Tonetto S, Fiorentino M, Todesco S (1994) Antiphospholipid antibody syndrome associated with ovarian cancer. A new paraneoplastic syndrome? J Rheumatol 21:2162–2163
41. Sequeira JF, Keser G, Greenstein B, Wheeler MJ, Duarte PC, Khamashta MA, Hughes GR (1993) Systemic lupus erythematosus: sex hormones in male patients. Lupus 2:315–317
42. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283:2008–2012
43. Sugai S, Palmer DW, Talal N, Witz IP (1974) Protective and cellular immune responses to idiotypic determinants on cells from a spontaneous lymphoma ofNZB-NZWF1 mice. J Exp Med 140:1547–1558
44. Sultan SM, Ioannou Y, Isenberg DA (2000) Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review. Rheumatology (Oxford) 39:1147–1152
45. Tarr T, Lakos G, Bhattoa HP, Soltesz P, Shoenfeld Y, Szegedi G, Kiss E (2007) Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up. Clin Rev Allergy Immunol 32:131–137
46. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2007) STROBE initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology 18:800–804
47. Wang J, Pan HF, Su H, Li XP, Xu JH, Ye DQ (2009) Tuberculosis in systemic lupus erythematosus in Chinese patients. Trop Dr 39:165–167
48. Wong WC, Cheung CS, Hart GJ (2008) Development of a quality assessment tool for systematic reviews of observational studies (QATSO) of HIV prevalence in men having sex with men and associated risk behaviours. Emerg Themes Epidemiol 17:5–23
49. Yu C, Gershwin ME, Chang C (2014) Diagnostic criteria for systemic lupus erythematosus: a critical review. J Autoimmun 48:10–13
50. Zintzaras E, Voulgarelis M, Moutsopoulos HM (2005) The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 165:2337–2344